Pembrolizumab and All-Trans Retinoic Acid Combination Treatment of Advanced Melanoma

Clinical trial NCT03200847 · COMPLETED

Trial details

NCT number: NCT03200847
Sponsor: University of Colorado, Denver
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Stage IV Melanoma Stage III Melanoma Advanced Melanoma

Start date: 2017-10-31
Primary completion: 2022-07-20
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.